Search Results - "Parker, Devin"

Cardiac Biomarkers Associated With Hospital Length of Stay After Pediatric Congenital Heart Surgery by Green, Michael D., Parker, Devin M., Everett, Allen D., Vricella, Luca, Jacobs, Marshall L., Jacobs, Jeffrey P., Brown, Jeremiah R.

“…Prolonged hospital length of stay after congenital heart surgery is a significant cost burden and is associated with postoperative morbidity. Our goal was to…”
Get full text

Site of Treatment for Non-Urgent Conditions by Medicare Beneficiaries: Is there a role for Urgent Care Centers? by Corwin, Gregory S., MPH, Parker, Devin M., MS, Brown, Jeremiah R., PhD

“…Abstract Purpose There is limited information on where and how often Medicare beneficiaries seek care for non-urgent conditions when a physician office visit…”
Get full text

Improving the prediction of long‐term readmission and mortality using a novel biomarker panel by Brown, Jeremiah R., Parker, Devin, Stabler, Meagan E., Jacobs, Marshall L., Jacobs, Jeffrey P., Everett, Allen D., Lobdell, Kevin W., Wyler von Ballmoos, Moritz C., Thiessen‐Philbrook, Heather, Parikh, Chirag, Mackenzie, Todd, DiScipio, Anthony, Malenka, David, Matheny, Michael E., Turchin, Alexander, Likosky, Donald S.

“…Objective Several short‐term readmission and mortality prediction models have been developed using clinical risk factors or biomarkers among patients…”
Get full text

Population-Based Estimates of the Prevalence of Children With Congenital Heart Disease and Associated Comorbidities in the United States by Parker, Devin M, Stabler, Meagan E, MacKenzie, Todd A, Zimmerman, Meghan S, Shi, Xun, Everett, Allen D, Bucholz, Emily M, Brown, Jeremiah R

“…Congenital heart defects (CHD) are the most common birth defects and previous estimates report the disease affects 1% of births annually in the United States…”
Get full text

Galectin-3 as a Predictor of Long-term Survival After Isolated Coronary Artery Bypass Grafting Surgery by Parker, Devin M., Owens, Sherry L., Ramkumar, Niveditta, Likosky, Donald, DiScipio, Anthony W., Malenka, David J., MacKenzie, Todd A., Brown, Jeremiah R.

“…Galectin-3 (Gal-3) is a well-established biomarker of adverse clinical outcomes, but its prognostic value for long-term survival after cardiac surgery is not…”
Get full text

Preoperative serum ST2 level predicts acute kidney injury after adult cardiac surgery by Lobdell, Kevin W., Parker, Devin M., Likosky, Donald S., Rezaee, Michael, Wyler von Ballmoos, Moritz, Alam, Shama S., Owens, Sherry, Thiessen-Philbrook, Heather, MacKenzie, Todd, Brown, Jeremiah R.

“…The purpose of this study was to evaluate the relationship between preoperative levels of serum soluble ST2 (ST2) and acute kidney injury (AKI) after cardiac…”
Get full text

Novel Biomarkers Improve Prediction of 365-Day Readmission After Pediatric Congenital Heart Surgery by Parker, Devin M., Everett, Allen D., Stabler, Meagan E., Vricella, Luca, Jacobs, Marshall L., Jacobs, Jeffrey P., Parikh, Chirag R., Pasquali, Sara K., Brown, Jeremiah R.

“…The purpose of this study was to evaluate the association between preoperative biomarker levels and 365-day readmission or mortality after pediatric congenital…”
Get full text

Utility of Biomarkers to Improve Prediction of Readmission or Mortality After Cardiac Surgery by Brown, Jeremiah R., Jacobs, Jeffrey P., Alam, Shama S., Thiessen-Philbrook, Heather, Everett, Allen, Likosky, Donald S., Lobdell, Kevin, Wyler von Ballmoos, Moritz C., Parker, Devin M., Garg, Amit X., Mackenzie, Todd, Jacobs, Marshall L., Parikh, Chirag R.

“…Hospital readmission within 30 days is associated with higher risks of complications, death, and increased costs. Accurate statistical models to stratify the…”
Get full text

Variation in Utilization and Need for Tympanostomy Tubes across England and New England by Parker, Devin M., MS, Schang, Laura, PhD, Wasserman, Jared R., MS, Viles, Weston D., PhD, Bevan, Gwyn, MA, Goodman, David C., MD, MS

“…Objectives To compare rates of typmanostomy tube insertions for otitis media with effusion with estimates of need in 2 countries. Study design This…”
Get full text

ST2 Predicts Risk of Unplanned Readmission Within 1 Year After Pediatric Congenital Heart Surgery by Parker, Devin M., Everett, Allen D., Stabler, Meagan E., Jacobs, Marshall L., Jacobs, Jeffrey P., Vricella, Luca, Thiessen-Philbrook, Heather, Parikh, Chirag R., Manlhiot, Cedric, Brown, Jeremiah R.

“…Approximately 10% to 20% of children are readmitted after congenital heart surgery. Very little is known about biomarkers as predictors of risk of unplanned…”
Get full text

Cardiac Biomarkers Predict Long-term Survival After Cardiac Surgery by Ramkumar, Niveditta, Jacobs, Jeffrey P., Berman, Richard B., Parker, Devin M., MacKenzie, Todd A., Likosky, Donald S., DiScipio, Anthony, Malenka, David J., Brown, Jeremiah R.

“…Cardiac biomarkers soluble ST-2 (sST-2) and N-terminal prohormone B-type natriuretic peptide (NT-proBNP) may be associated with long-term survival after…”
Get full text

Do minority and poor neighborhoods have higher access to fast-food restaurants in the United States? by James, Peter, Arcaya, Mariana C., Parker, Devin M., Tucker-Seeley, Reginald D., Subramanian, S.V.

“…Disproportionate access to unhealthy foods in poor or minority neighborhoods may be a primary determinant of obesity disparities. We investigated whether…”
Get full text

The Association Between Novel Biomarkers and 1-Year Readmission or Mortality After Cardiac Surgery by Jacobs, Jeffrey P., Alam, Shama S., Owens, Sherry L., Parker, Devin M., Rezaee, Michael, Likosky, Donald S., Shahian, David M., Jacobs, Marshall L., Thiessen-Philbrook, Heather, Wyler von Ballmoos, Moritz, Lobdell, Kevin, MacKenzie, Todd, Everett, Allen D., Parikh, Chirag R., Brown, Jeremiah R.

“…Novel cardiac biomarkers including soluble suppression of tumorigenicity 2, galectin-3, and the N-terminal prohormone of brain natriuretic peptide may be…”
Get full text

Excess Readmission vs Excess Penalties: Maximum Readmission Penalties as a Function of Socioeconomics and Geography by Caracciolo, Chris M., Parker, Devin M., Marshall, Emily, Brown, Jeremiah R.

“…BACKGROUND The Hospital Readmission Reduction Program (HRRP) penalizes hospitals with “excess” readmissions up to 3% of Medicare reimbursement. Approximately…”
Get full text

Biomarkers for the prediction of cardiac readmission by Parker, Devin M, Brown, Jeremiah R

“…Novel biomarkers (ST2, galectin-3 and cystatin C) and established biomarkers (BNP, cardiac troponin T and IL-6) that are linked to the primary causes of…”
Get full text

Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery by Polineni, Sai, Parker, Devin M, Alam, Shama S, Thiessen-Philbrook, Heather, McArthur, Eric, DiScipio, Anthony W, Malenka, David J, Parikh, Chirag R, Garg, Amit X, Brown, Jeremiah R

“…Current preoperative models use clinical risk factors alone in estimating risk of in-hospital mortality following cardiac surgery. However, novel biomarkers…”
Get full text

Biomarkers associated with 30‐day readmission and mortality after pediatric congenital heart surgery by Parker, Devin M., Everett, Allen D., Stabler, Meagan E., Vricella, Luca, Jacobs, Marshall L., Jacobs, Jeffrey P., Thiessen‐Philbrook, Heather, Parikh, Chirag R., Brown, Jeremiah R.

“…Objectives Novel cardiac biomarkers serum (suppression of tumorigenicity [ST2]) and Galectin‐3 may be associated with an increased likelihood of important…”
Get full text

sST2 as a novel biomarker for the prediction of in-hospital mortality after coronary artery bypass grafting by Stabler, Meagan E., Rezaee, Michael E., Parker, Devin M., MacKenzie, Todd A., Bohm, Andrew R., DiScipio, Anthony W., Malenka, David J., Brown, Jeremiah R.

“…Objectives: Soluble suppression of tumorigenicity 2 (sST2) biomarker is an emerging predictor of adverse clinical outcomes, but its prognostic value for…”
Get full text

Biomarkers improve prediction of 30-day unplanned readmission or mortality after paediatric congenital heart surgery by Brown, Jeremiah R, Stabler, Meagan E, Parker, Devin M, Vricella, Luca, Pasquali, Sara, Leyenaar, JoAnna K, Bohm, Andrew R, MacKenzie, Todd, Parikh, Chirag, Jacobs, Marshall L, Jacobs, Jeffrey P, Everett, Allen D

“…To evaluate the association between novel pre- and post-operative biomarker levels and 30-day unplanned readmission or mortality after paediatric congenital…”
Get more information

Elevated preoperative Galectin-3 is associated with acute kidney injury after cardiac surgery by Wyler von Ballmoos, Moritz, Likosky, Donald S, Rezaee, Michael, Lobdell, Kevin, Alam, Shama, Parker, Devin, Owens, Sherry, Thiessen-Philbrook, Heather, MacKenzie, Todd, Brown, Jeremiah R

“…Previous research suggests that novel biomarkers may be used to identify patients at increased risk of acute kidney injury following cardiac surgery. The…”
Get full text